Diampa LT is a combination medication containing two active ingredients: Empagliflozin and Linagliptin.
Empagliflozin: This is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to treat type 2 diabetes. It works by reducing glucose reabsorption in the kidneys, leading to increased glucose excretion in urine and lowered blood sugar levels.
Linagliptin: This is a dipeptidyl peptidase-4 (DPP-4) inhibitor used for type 2 diabetes. It helps increase insulin secretion and decrease glucose production, contributing to better blood sugar control.
Diampa LT combines these two medications to provide a dual approach in managing blood sugar levels for people with type 2 diabetes. Always follow your healthcare provider's instructions when taking Diampa LT and be aware of potential side effects and interactions. Consult a healthcare professional before starting or stopping any medication.medichussain
Comments
Post a Comment